B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 5 53-5, 2003, Pages

  D'Souza, Savio P ^a   Yellon, Derek M ^a   Martin, Claus ^b   Schulz, Rainer ^b   Heusch, Gerd ^b   Onody, Annamaria ^c   Ferdinandy, Peter ^c   Baxter, Gary F ^d  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF SZEGED   (Hungary)

^d ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

cGMP; Infarct size; Ischemia reperfusion; Preconditioning

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE; BRAIN NATRIURETIC PEPTIDE; CLAMIKALANT; GLIBENCLAMIDE; POTASSIUM CHANNEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART PROTECTION; ISOLATED HEART; MALE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; RAT; SARCOLEMMA;

EID: 0037405193     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00902.2002     Document Type: Article

References (40)

1. Baxter GF and Ebrahim Z. Role of bradykinin in preconditioning and protection of the ischaemic myocardium. Br J Pharmacol 135: 843-854, 2002.
2. Boomsma F and van den Meiracker AH. Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical use. Cardiovasc Res 51: 442-449, 2001.
3. Brunner F and Wolkart G. Endothelial NO/cGMP system contributes to natriuretic peptide-mediated coronary and peripheral vasodilation. Microvasc Res 61: 102-110, 2201.
4. Chinkers M and Garbers DL. Signal transduction by guanylyl cyclases. Annu Rev Biochem 60: 553-575, 1991.
5. Csont T, Pali T, Szilvassy Z, and Ferdinandy P. Lack of correlation between myocardial nitric oxide and cyclic guanosine monophosphate content in both nitrate-tolerant and -nontolerant rats. Biochem Pharmacol 56: 1139-1144, 1998.
6. Espiner EA, Richards AM, Yandle TG, and Nicholls MG. Natriuretic hormones. Endocrinol Metab Clin North Am 24: 481-509, 1995.
7. ATP channel modulation in working rat hearts with coronary occlusion: effects of cromakalim, cicletanine, and glibenclamide. Cardiovasc Res 30: 781-787, 1995.
8. Gross GJ. ATP-sensitive potassium channels and myocardial preconditioning. Basic Res Cardiol 90: 85-88, 1995.
9. Grover GJ. Protective effects of ATP sensitive potassium channel openers in models of myocardial ischemia. Cardiovasc Res 28: 778-782, 1994.
10. + channel activation by nitric oxide and protein kinase G in rabbit ventricular myocytes. Am J Physiol Heart Circ Physiol 283: H1545-H1554, 2002.
11. Hove-Madsen L, Mery PF, Jurevicius J, Skeberdis AV, and Fischmeister R. Regulation of myocardial calcium channels by cyclic AMP metabolism. Basic Res Cardiol 91: 1-8, 1996.
12. Izumi T, Saito Y, Kishimoto I, Harada M, Kuwahara K, Hamanaka I, Takahashi N, Kawakami R, Li Y, Takemura G, Fujiwara H, Garbers DL, Mochizuki S, and Nakao K. Blockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-kappaB activation and alleviates myocardial ischemia/reperfusion injury. J Clin Invest 108: 203-213, 2001.
13. Kambayashi Y, Nakao K, Kimura H, Kawabata T, Nakamura M, Inouye K, Yoshida N, and Imura H. Biological characterization of human brain natriuretic peptide (BNP) and rat BNP: species-specific actions of BNP. Biochem Biophys Res Commun 173: 599-605, 1990.
14. ATP channel. Cardiovasc Drugs Ther 14: 497-502, 2000.
15. Koller KJ and Goeddel DV. Molecular biology of the natriuretic peptides and their receptors. Circulation 86: 1081-1088, 1992.
16. + channels in cultured vascular smooth muscle cells. Circ Res 74: 471-476, 1994.
17. Legtenberg RJ, Houston RJ, Oeseburg B, and Smits P. Effects of sulfonylurea derivatives on ischemia-induced loss of function in the isolated rat heart. Eur J Pharmacol 419: 85-92, 2001.
18. Lohmann SM, Fischmeister R, and Walter U. Signal transduction by cGMP in heart. Basic Res Cardiol 86: 503-514, 1991.
19. Loweth AC, Williams GT, Scarpello JHB, and Morgan NG. Evidence for the involvement of cGMP and protein kinase G in nitric oxide-induced apoptosis in the pancreatic B-cell line, HIT-T15. FEBS Lett 400: 285-288, 1997.
20. Lucas KA, Pitari GM, Kazerounian S, Ruiz-Stewart I, Park J, Schulz S, Chepenik KP, and Waldman SA. Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52: 375-414, 2000.
21. ATP channels. Br J Pharmacol 135: 480-488, 2000.
22. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 268: 26286-36295, 1993.
23. Mocanu MM, Maddock HL, Baxter GF, Lawrence CL, Standen NB, and Yellon DM. Glimepiride, a novel sulphonylureas, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide. Circulation 103: 3111-3116, 2001.
24. Nakamura S, Naruse M, Naruse K, Kawana M, Nishikawa T, Hosoda S, Tanaka I, Yoshimi T, Yoshihara I, and Inagami T. Atrial natriuretic peptide and brain natriuretic peptide coexist in the secretory granules of human cardiac myocytes. Am J Hypertens 4: 909-912, 1991.
25. Nakamura Y, Yasuda M, Fujimori H, and Kiyono M. Cytotoxic effect of sodium nitroprusside on P.C12 cells. Chemosphere 34: 317-324, 1197.
26. Opie LH. Role of cyclic nucleotides in heart metabolism. Cardiovasc Res 16: 483-507, 1982.
27. Padilla F, Garcia-Dorado D, Agullo L, Barrabes JA, Inserte J, Escalona N, Meyer M, Mirabet M, Pina P, and Soler-Soler J. Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs. Cardiovasc Res 51: 592-600, 2001.
28. Schulz R, Cohen MV, Behrends M, Downey JM, and Heusch G. Signal transduction of ischemic preconditioning. Cardiovasc Res 52: 181-198, 2001.
29. Silberbach M and Roberts CT Jr. Natriuretic peptide signalling: molecular and cellular pathways to growth regulation. Cell Signal 13: 221-231, 2001.
30. Takagi G, Kiuchi K, Endo T, Yamamoto T, Sato N, Nejima J, and Takano T. Alpha-human atrial natriuretic peptide, carperitide, reduces infarct size but not arrhythmias after coronary occlusion/reperfusion in dogs. J Cardiovasc Pharmacol 36: 22-30, 2000.
31. Takuma K, Phuagphong P, Lee E, Mori K, Baba A, and Matsuda T. Anti-apoptotic effect of cGMP in cultured astrocytes: inhibition by cGMP-dependent protein kinase of mitochondrial permeable transition pore. J Biol Chem 276: 48093-48099, 2001.
32. Talwar S, Squire IB, Downie PF, Davies JE, and Ng LL. Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart 84: 421-424, 2000.
33. Tateishi J, Masutani M, Ohyanagi M, and Iwasaki T. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol 23: 776-780, 2000.
34. Tepperman BL, Abrahamson TD, and Soper BD. The role of cyclic gunaylate monophosphate in nitric oxide-induced injury to rat small intestinal epithelial cells. J Pharmacol Exp Ther 284: 929-933, 1998.
35. Toth M, Vuorinen KH, Vuolteenaho O, Hassinen IE, Uusimaa PA, Leppaluoto J, and Ruskoaho H. Hypoxia stimulates release of ANP and BNP from perfused rat ventricular myocardium. Am J Physiol Heart Circ Physiol 266: H1572-H1580, 1994.
36. ATP channels. Am J Physiol Heart Circ Physiol 280: H2321-H2328, 2001.
37. ATP channels open as a prominent and early feature during ischemia in the Langendorff-perfused rat heart? Basic Res Cardiol 95: 250-260, 2000.
38. Yamamoto K, Burnett JC Jr, and Redfield MM. Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart. Am J Physiol Heart Circ Physiol 273: H2406-H2414, 1997.
39. Yoshimura M, Yasue H, Morita E, Sakaino N, Jougasaki M, Kurose M, Mukoyama M, Saito Y, Nakao K, and Imura H. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 84: 1581-1588, 1991.
40. Zellner C, Protter AA, Ko E, Pothireddy MR, DeMarco T, Hutchison SJ, Chou TM, Chatterjee K, and Sudhir K. Coronary vasodilator effects of BNP: mechanisms of action in coronary conductance and resistance arteries. Am J Physiol Heart Circ Physiol 276: H1049-H1057, 1999.